Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financi...(ertible preferred stock and stockhol...),Health

Date:3/23/2009

ertible preferred stock and stockholders' equity (net capital deficiency) Current liabilities: Accounts payable $575,269 $817,695 Accrued liabilities 1,468,415 2,008,580 Loan payable short-term portion 3,347,010 3,527,016 --------- --------- Total current liabilities 5,390,694 6,353,291 Warrant liability 599,845 967,967 Deposit for stock purchase 87,656 135,491 Deferred rent 77,044 73,907 Loan payable long-term portion 169,636 3,516,646 ------- --------- Total liabilities 6,324,875 11,047,302 --------- ---------- Commitments and contingencies Convertible preferred stock: Series A convertible preferred stock, $0.001 par value; 426,008 shares authorized; 426,008 shares issued and outstanding at December 31, 2008 and 2007, (aggregate liquidation preference of $426,008 as of December 31, 2008), net of issuance costs of $17,982 408,026 408,026 Series B convertible preferred stock, $0.001 par value; 7,966,748 shares authorized; 7,966,748 shares issued and outstanding at December 31, 2008 and 2007, (aggregate liquidation preference of $7,966,748 as of December 31, 2008), net of issuance costs of $123,490 7,843,258 7,843,258 Series C convertible preferred stock, $0.001 par value; 21,300,000 shares authorized; 20,079,889 shares issued and outstanding at December 31, 2008 and 2007, (aggregate liquidati
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
2. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
3. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
4. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
5. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
6. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
7. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
8. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
9. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
10. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference